The effects of albendazole and albendazole sulphoxide combination-therapy on Echinococcus granulosus in vitro.
Protoscoleces of Echinococcus granulosus were incubated in vitro with decreasing concentrations of either albendazole (ABZ) or albendazole sulphoxide (ABZ.SO) (50, 10, 1 and 0.1 micrograms ml-1), and in combination. Viability was assessed by the methylene blue exclusion test and establishment of infection in mice. Protoscolex ultrastructure was determined by means of transmission and scanning electron microscopy. ABZ and ABZ.SO, when used separately had protoscolicidal activity after a longer incubation period (30 days) than when used as combined compounds. When incubated in the presence of ABZ + ABZ.SO, protoscolex viability dropped rapidly. That is, protoscoleces were all non-viable at 12 days of exposure, with no cyst developing following their inoculation into mice. The ultrastructural changes induced by ABZ or ABZ.SO alone, were: (a) rostellar disorganization, (b) formation of numerous blebs on the tegument, (c) loss of the microtriches, (d) increased vesiculation within the tegumentary cytons together, (e) an increase in lipid deposits and (f) depletion of glycogen reserves. After incubation with combined ABZ and ABZ.SO the tegument contained numerous blebs which became detached, leaving debris only, some intact nuclei being discernible in the protoscolex parenchyma.
Laboratory of Parasitology, Faculty of Pharmacy, University of Alcalá de Henares, Madrid, Spain.
J
J
Pérez-Serrano
N
N
Casado
Guillermo
Denegri
F
F
Rodriguez-Caabeiro
D015766:Albendazole / Q000031:analogs & derivatives* / Q000494:pharmacology*; D000818:Animals; D000871:Anthelmintics / Q000494:pharmacology*; D003470:Culture Media; D004338:Drug Combinations; D004446:Echinococcus / Q000187:drug effects* / Q000648:ultrastructure; D008854:Microscopy, Electron; D008855:Microscopy, Electron, Scanning
D000871:Anthelmintics; D003470:Culture Media; D004338:Drug Combinations; D015766:Albendazole; C027186:albendazole sulfoxide